2019 U.S.-Booked Air Volume: $100 million
Consolidated U.S. TMC: CWT
Pharmaceutical firm Novartis spent about 5 percent more on U.S.-booked air travel in 2019 than it did a year prior, BTN estimates. The company's net income for its most recent fiscal year was down about 7 percent to $11.7 billion. Novartis completed the acquisition of The Medicines Company in January 2020, and in September, Germany's BioNTech purchased a biotech production site in Germany with about 300 employees from the company to boost output of its coronavirus vaccine. Novartis's workforce in 2019 totaled 103,914, down 866 people from a year prior. The company's sustainability goal is to achieve full carbon neutrality for itself as well as its supply chain by 2030. About 30,000 Novartis employees are frequent international travelers, and 1,300 are international assignees, which equates to over 250,000 trips annually to all areas of the globe, according to the company's latest CSR report. The company's Scope 3 business travel carbon emissions were down about 3 percent in 2019, to 205.8 metric tons.